Table 2. Values of epilepsy biomarkers in epileptogenesis and ictogenesis.
| 1. | to predict the development of an epilepsy condition |
| 2. | to identify the presence of tissue capable of generating spontaneous seizures |
| 3. | to measure progression after the condition is established |
| 4. | to be used to create animal models for more cost-efficient screening of potential antiepileptogenic and antiseizure drugs and devices |
| 5. | to reduce the cost of clinical trials of potential antieipleptogenic interventions by enriching the trial population with patients at high risk for developing epilepsy |
Quotation from the report of the biomarker subgroup in ILAE London Workshop [22]; Ictogenesis, The process by which the brain develops seizures; Epileptogenesis, The process by which the brain develops epilepsy.